Cargando…

Objective evaluation of the nasal mucosal secretion in COVID-19 patients with anosmia

BACKGROUND: COVID-19 is a new disease caused by the SARS-CoV-2 virus. The olfactory dysfunction linked to COVID-19 is not associated with rhinorrhea but there is no objective evaluation. AIMS: To evaluate nasal mucosal secretion objectively in COVID-19 patients with anosmia. METHODS: Fifty-two COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Islamoglu, Yuce, Gemcioglu, Emin, Ates, Ihsan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570413/ https://www.ncbi.nlm.nih.gov/pubmed/33074449 http://dx.doi.org/10.1007/s11845-020-02405-1

Ejemplares similares

False positivity of Rose Bengal test in patients with COVID-19: case series, uncontrolled longitudinal study
por: Gemcioglu, Emin, et al.
Publicado: (2020)

Nasal Microbiome in COVID-19: A Potential Role of Corynebacterium in Anosmia
por: Nardelli, Carmela, et al.
Publicado: (2022)

Magnetic resonance imaging findings in COVID-19-related anosmia
por: ÇETİN, Hüseyin, et al.
Publicado: (2021)

Anosmia in COVID-19 patients
por: Hornuss, D., et al.
Publicado: (2020)

Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients
por: San, Ishak, et al.
Publicado: (2021)

Persistent Nasal Inflammation 5 Months after Acute Anosmia in Patients with COVID-19
por: Hua-Huy, Thông, et al.
Publicado: (2021)

The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated
por: Lechien, Jerome R., et al.
Publicado: (2021)

Effect of intranasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVID-19 patients
por: İslamoglu, Yuce
Publicado: (2022)

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients()
por: Singh, Chandra Veer, et al.
Publicado: (2021)

Features of anosmia in COVID-19
por: Klopfenstein, T., et al.
Publicado: (2020)

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients
por: Singh, Chandra Veer, et al.
Publicado: (2021)

Possible Role of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Recovery of Post-COVID-19 Anosmia
por: Aref, Zaki F, et al.
Publicado: (2022)

Association of COVID-19 with Anosmia and Hypogeusia
por: Nasir, Saad, et al.
Publicado: (2020)

COVID-19 and anosmia in Tehran, Iran
por: Gilani, Sapideh, et al.
Publicado: (2020)

Monitoring of cases of anosmia and COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Transport of awake hypoxemic probable COVID 19 patients in the prone position
por: Şan, İshak, et al.
Publicado: (2021)

Facial paralysis as the only symptom of COVID-19: A prospective study
por: Islamoglu, Yuce, et al.
Publicado: (2021)

Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients”
por: Verma, Ravneet Ravinder, et al.
Publicado: (2021)

Incidence of Anosmia among Covid 19 patients in India
por: Aanand, Prem, et al.
Publicado: (2021)

Intra‐nasal zinc level relationship to COVID‐19 anosmia and type 1 interferon response: A proposal
por: Equils, Ozlem, et al.
Publicado: (2020)

Beware of traumatic anosmia in COVID-19 pandemic
por: Nagamine, Takahiko
Publicado: (2021)

COVID-19 and Anosmia: Remaining Gaps to Knowledge
por: Brandão Neto, Deusdedit, et al.
Publicado: (2021)

The aftermath of COVID-19: between anosmia and ageusia()
por: Medina Gamero, Aldo, et al.
Publicado: (2022)

“Anosmia” the mysterious collateral damage of COVID-19
por: Ahmed, Abdulrahman K., et al.
Publicado: (2022)

COVID‐19, anosmia, and ageusia in atopic children
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2022)

Anosmia—An Effect of COVID-19 Infection-Review
por: Shamsundara, Manaswi, et al.
Publicado: (2022)

COVID-19 patient with recurrent anosmia and its impact on management
por: Rizki, N.A., et al.
Publicado: (2022)

Factors associated with anosmia recovery rate in COVID‐19 patients
por: Babaei, Amirhossein, et al.
Publicado: (2021)

Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study
por: Rashid, Rasheed Ali, et al.
Publicado: (2021)

SARS-CoV-2 is not found in the sweat of COVID-19 positive patients
por: Arslan, Bengi, et al.
Publicado: (2021)

Changes in inflammatory biomarkers in the nasal mucosal secretion after septoplasty
por: Park, Marn Joon, et al.
Publicado: (2022)

Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine
por: Francavilla, Beatrice, et al.
Publicado: (2022)

Anosmia and ageusia
por: Tarakji, B., et al.
Publicado: (2020)

Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission
por: Gemcioglu, Emin, et al.
Publicado: (2021)

Olfactory Cleft Measurements and COVID-19–Related Anosmia
por: Altundag, Aytug, et al.
Publicado: (2020)

Potential Mechanisms for COVID-19 Induced Anosmia and Dysgeusia
por: Eshraghi, Adrien A., et al.
Publicado: (2020)

Anosmia is associated with lower in-hospital mortality in COVID-19
por: Talavera, Blanca, et al.
Publicado: (2020)

Anosmia in the course of COVID-19: A case report
por: Pissurno, Neisa Santos Carvalho Alves, et al.
Publicado: (2020)

Thalassemic Child Presenting with Anosmia due to COVID-19
por: Marhaeni, Wulandewi, et al.
Publicado: (2020)

Anosmia and dysgeusia in COVID-19: A systematic review
por: Carrillo-Larco, Rodrigo M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3dfhgdm1avru0q59nk1fvgn5do